Sandoz Inc Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Sandoz Inc's Family Patents


Family Patents



Sandoz Inc Drug List

Given below is the complete list of Sandoz Inc's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sandoz Inc News

Regeneron and Bayer's attempt to prevent Sandoz from introducing an Eylea biosimilar has been unsuccessful | Lawyerly

08 Sep, 2025

Sandoz's Strategic Growth in Generic Anticoagulants and Its Impact on the Development of Biosimilars

28 Aug, 2025

Data indicates that Health Canada is experiencing delays in the approval process for generic medications.

06 Aug, 2025

Market Analysis and Forecast for Generic Injectable Medications Through 2034

05 Aug, 2025

See More